Why 2 C3.ai Analysts Are Sidelined After Guidance Disappointment

Zinger Key Points
  • JMP's Patrick Walravens reiterated a Market Outperform rating while lowering the price target from $28 to $25.
  • “While the road has been very bumpy for C3 and investors are justifiably skeptical, we continue to like the long-term opportunity."

Shares of C3.ai Inc AI were down 20% ahead of the close Thursday in the wake of a quarterly report that saw sales fall short of expectations and the lowering of the artificial intelligence company's guidance. 

Piper Sandler On C3.ai

Analyst Arvind Ramnani maintained a Neutral rating while reducing the price target from $18 to $14.

“The company announced a shift to consumption-based pricing, which it expects to help it emerge as a stronger company in a stabilized environment, and moved its target for non-GAAP profitability forward to FY24 (from FY24- FY25),” Ramnani said in a note.

“In our view, the company's lowered revenue target is disappointing because initial guidance was already modest; however, we view increased focus on margins as positive,” he added.

Check out other analyst stock ratings.

JMP Securities On C3.ai

Analyst Patrick Walravens reiterated a Market Outperform rating while lowering the price target from $28 to $25.

“Guidance was disappointing as C3.ai is facing a more difficult business environment, saw 66 deals move out of the quarter, and, in response is moving to a consumption-based pricing model,” Walravens wrote in a note.

“While the road has been very bumpy for C3 and investors are justifiably skeptical, we continue to like the long-term opportunity at C3,” he added.

AI Price Action: Shares of C3.ai were down 20% at $14.40 Thursday afternoon ahead of the close. 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!